Outlook Therapeutics Announces $5M Registered Direct Offering For 16,129,033 Shares At $0.31/Share

Benzinga Newsdesk www.benzinga.com Neutral 92.9%

Neg 0% Neu 92.9% Pos 0%

Comments

No comments yet. Be the first!